Amantadine works through several distinct mechanisms depending on what it’s being used for. Originally developed as an antiviral drug against influenza A, it was later discovered to affect dopamine signaling in the brain, which led to its use in Parkinson’s disease and traumatic brain injury recovery. Its most important neurological effect appears to be blocking a specific type of receptor in the brain called the NMDA receptor, which indirectly boosts dopamine activity.
How It Works Against Influenza A
Influenza A viruses have a protein called M2 embedded in their outer shell that acts as a tiny ion channel, letting charged particles flow in and out of the virus. When the virus enters one of your cells, it gets trapped inside a small compartment that gradually becomes more acidic. That acidity activates the M2 channel, which allows hydrogen ions to flood into the viral core. This loosens the virus’s internal structure, a step called “uncoating,” and releases the viral genetic material so it can hijack your cell’s machinery to make copies of itself.
Amantadine physically blocks the M2 ion channel, preventing that flow of hydrogen ions. Without uncoating, the virus can’t replicate. This mechanism only works against influenza A, since influenza B viruses don’t have the M2 protein.
In practice, though, amantadine is no longer recommended for treating or preventing the flu. Nearly all circulating seasonal influenza A strains in the United States are now resistant to it, according to the CDC. Widespread resistance to this class of drugs (called adamantanes) has made newer antivirals the standard treatment instead.
How It Affects the Brain in Parkinson’s Disease
The neurological mechanism of amantadine is more complex and involves multiple pathways, but NMDA receptor antagonism appears to be the most relevant. NMDA receptors are found throughout the brain and play a role in excitatory signaling between nerve cells. By blocking these receptors, amantadine reduces excessive excitatory activity in movement-related brain circuits, which helps ease the stiffness, tremors, and slowness characteristic of Parkinson’s disease.
Blocking NMDA receptors also has a secondary effect: it stimulates the enzyme that produces dopamine in the striatum, a brain region central to movement control. This means amantadine doesn’t just calm overactive circuits; it also helps increase dopamine levels in the area where Parkinson’s patients need it most. On top of that, amantadine inhibits the reuptake of dopamine, meaning dopamine that’s already been released stays active in the gap between nerve cells for longer. Research published in Brain Research confirmed that amantadine increases dopamine levels in the striatum through both of these routes simultaneously.
Amantadine also has mild anticholinergic-like effects, reducing the activity of another neurotransmitter called acetylcholine. This contributes to some of its therapeutic benefit in Parkinson’s, since dopamine and acetylcholine normally balance each other in movement circuits. When dopamine drops in Parkinson’s, acetylcholine activity becomes relatively overactive, so dampening it helps restore some balance. These same anticholinergic properties, however, are also responsible for common side effects like dry mouth, constipation, and urinary retention.
Use in Traumatic Brain Injury
Amantadine is one of the most commonly used drugs for patients recovering from traumatic brain injury, particularly those in comatose or vegetative states. The same dopamine-boosting and NMDA-blocking mechanisms that help in Parkinson’s disease also appear to enhance arousal and behavioral responsiveness after severe brain injuries. Clinical practice guidelines now recommend escalating doses of amantadine (up to 400 mg daily) for patients with impaired consciousness following brain trauma.
In recovering patients, amantadine has been shown to improve attention and concentration while reducing fatigue. An expert panel reviewing the evidence concluded that amantadine can facilitate arousal in comatose or vegetative patients, though the benefits for sustained attention over the longer term are less clear. It may also help normalize behavioral disturbances during recovery, such as agitation and irritability, which are common after serious brain injuries.
How the Body Processes Amantadine
Amantadine is well absorbed when taken by mouth, reaching peak blood levels in about 2 to 4 hours. It has a relatively long half-life, averaging around 16 to 17 hours, which means it stays active in the body long enough for once- or twice-daily dosing in most cases. The range is wide, though, from 9 to 31 hours depending on the individual.
The kidneys do nearly all the work of clearing amantadine from the body. The drug is primarily excreted unchanged in urine, with only 5 to 15% converted into a metabolite before elimination. This heavy reliance on kidney function means that people with reduced kidney capacity need significantly adjusted dosing. For someone with moderately impaired kidney function, the dose might be cut in half. For someone with severe impairment or on dialysis, the standard dose might only be given once a week to prevent the drug from accumulating to dangerous levels.
Notable Side Effects
Beyond the anticholinergic effects already mentioned (dry mouth, constipation, urinary retention), amantadine has a distinctive side effect that catches many patients off guard: livedo reticularis, a lace-like, bluish-red mottling of the skin, most commonly on the legs and trunk. Up to 40% of patients on long-term amantadine develop this pattern, with women affected more often than men. It results from changes in how small blood vessels in the skin constrict, and it typically resolves after stopping the drug. While it looks alarming, livedo reticularis from amantadine doesn’t involve the internal organs and is considered a cosmetic rather than dangerous side effect.
Because amantadine has anticholinergic-like properties, combining it with other medications that share those effects (such as certain antihistamines, bladder medications, or older antidepressants) can amplify side effects. If dry mouth, blurred vision, or confusion worsens after adding another medication, the overlap in anticholinergic activity is the likely explanation, and one of the drugs may need a dose reduction.